Alzheimers New Drug Approved by FDA Storyboard
Търсене

Alzheimers New Drug Approved by FDA

Копирайте този Storyboard
Alzheimers New Drug Approved by FDA

Описание на Статията

PME 815

Текст на Статията

  • Пързалка: 1
  • News Stand
  • “Alzheimer’s Cure Approved by FDA – Only One Pill Needed!”
  • Пързалка: 2
  • “Wow, I should share this!” -- Texts a friend
  • Пързалка: 3
  • “Are you sure it’s real? We should use facts checking tools, try to find the original source and verify and check other sources just to make sure.”
  • Skepticism ensues....
  • Пързалка: 4
  • Searches for information on the FDA’s website, discovering that the new Alzheimer’s treatment, Lecanemab, is not a cure and has limitations.
  • FDA
  • Пързалка: 5
  • Let's consult the Mayo Clinic . They found that Lecanemab slows symptoms in early cases but has severe risks, including brain swelling.
  • Пързалка: 6
  • “Imagine if social media flagged questionable health news and provided a ‘Read More’ option to check reliable sources.”
  • Maybe platforms could highlight credible sources when using information from them .
  • Пързалка: 7
  • Another source shows the drug costs $26,500 annually. That’s not affordable for everyone, jeepers!
  • Пързалка: 8
  • So basically, Lecanemab helps some early-stage patients but isn’t a cure, comes with risks, and is expensive.
  • Пързалка: 9
  • “To be a responsible digital citizen, always verify health claims and question headlines.”
  • Пързалка: 10
  • Sources:Alzheimer's Association. “Donanemab for Treatment of Early Alzheimer’s Disease — News Pending FDA Review.” Alzheimer’s Disease and Dementia, 2023, www.alz.org/alzheimers-dementia/treatments/donanemab. Canadian Teachers’ Federation. (2021, February 22). Break the fake [Video]. YouTube. https://www.youtube.com/watch?v=qHeNabULAE0 Salam, Erum. “FDA Approves Breakthrough Alzheimer’s Drug Lecanemab.” The Guardian, 6 Jan. 2023, www.theguardian.com/us-news/2023/jan/06/fda-approves-breakthrough-alzheimers-drug-lecanemab.Stiepan, DeeDee. “Alzheimer’s Drug Lecanemab Granted Full Approval by FDA, Mayo Clinic Expert Weighs In.” Mayo Clinic News Network, 6 July 2023, newsnetwork.mayoclinic.org/discussion/alzheimers-drug-lecanemab-granted-full-approval-by-fda-mayo-clinic-expert-weighs-in/.
Създадени са над 40 милиона сценария
Без Изтегляния, без Кредитна Карта и без Регистрация, за да Опитате!
Storyboard That Family